
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Emerging role of ferroptosis in glioblastoma: Therapeutic opportunities and challenges
Shenghua Zhuo, Guiying He, Taixue Chen, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 19
Shenghua Zhuo, Guiying He, Taixue Chen, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 19
Showing 19 citing articles:
Interplay of Ferroptosis and Cuproptosis in Cancer: Dissecting Metal-Driven Mechanisms for Therapeutic Potentials
Jinjiang Wang, Jiaxi Li, Jiao Liu, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 512-512
Open Access | Times Cited: 22
Jinjiang Wang, Jiaxi Li, Jiao Liu, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 512-512
Open Access | Times Cited: 22
Diethyldithiocarbamate-ferrous oxide nanoparticles inhibit human and mouse glioblastoma stemness: aldehyde dehydrogenase 1A1 suppression and ferroptosis induction
Marwa M. Abu‐Serie, Satoru Osuka, Lamiaa A Heikal, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 8
Marwa M. Abu‐Serie, Satoru Osuka, Lamiaa A Heikal, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 8
Global Research Landscape and Hotspots for Ferroptosis in Glioma: A Comprehensive Bibliometric and Visual Analysis
Xiaoyang Zheng, Ming Diao, Shan Tong, et al.
Heliyon (2025), pp. e42242-e42242
Open Access | Times Cited: 1
Xiaoyang Zheng, Ming Diao, Shan Tong, et al.
Heliyon (2025), pp. e42242-e42242
Open Access | Times Cited: 1
Implantation of hydrogel-liposome nanoplatform inhibits glioblastoma relapse by inducing ferroptosis
Zixiao Wang, Zihao Liu, Shan Wang, et al.
Asian Journal of Pharmaceutical Sciences (2023) Vol. 18, Iss. 3, pp. 100800-100800
Open Access | Times Cited: 19
Zixiao Wang, Zihao Liu, Shan Wang, et al.
Asian Journal of Pharmaceutical Sciences (2023) Vol. 18, Iss. 3, pp. 100800-100800
Open Access | Times Cited: 19
Emerging Lipid Targets in Glioblastoma
Ammar Darwish, Milán Pammer, Ferenc Gallyas, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 397-397
Open Access | Times Cited: 7
Ammar Darwish, Milán Pammer, Ferenc Gallyas, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 397-397
Open Access | Times Cited: 7
Impact of ferroptosis-related risk genes on macrophage M1/M2 polarization and prognosis in glioblastoma
Xin Xu, Yue Zhang, Chenlong Liao, et al.
Frontiers in Cellular Neuroscience (2024) Vol. 17
Open Access | Times Cited: 6
Xin Xu, Yue Zhang, Chenlong Liao, et al.
Frontiers in Cellular Neuroscience (2024) Vol. 17
Open Access | Times Cited: 6
Ferroptosis in glioma therapy: advancements in sensitizing strategies and the complex tumor-promoting roles
Soo Yeon Kim, Miaolu Tang, Tong Lu, et al.
Brain Research (2024) Vol. 1840, pp. 149045-149045
Closed Access | Times Cited: 4
Soo Yeon Kim, Miaolu Tang, Tong Lu, et al.
Brain Research (2024) Vol. 1840, pp. 149045-149045
Closed Access | Times Cited: 4
Broadening horizons: research on ferroptosis in lung cancer and its potential therapeutic targets
Guangpeng Gao, Xindi Zhang
Frontiers in Immunology (2025) Vol. 16
Open Access
Guangpeng Gao, Xindi Zhang
Frontiers in Immunology (2025) Vol. 16
Open Access
Targeting metabolic reprogramming in glioblastoma as a new strategy to overcome therapy resistance
Simona D’Aprile, Simona Denaro, Anna Gervasi, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
Simona D’Aprile, Simona Denaro, Anna Gervasi, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
Therapeutic and prognostic values of ferroptosis signature in glioblastoma
Reza Nedaeinia, Hassan Dianat‐Moghadam, Maedeh Movahednasab, et al.
International Immunopharmacology (2025) Vol. 155, pp. 114597-114597
Closed Access
Reza Nedaeinia, Hassan Dianat‐Moghadam, Maedeh Movahednasab, et al.
International Immunopharmacology (2025) Vol. 155, pp. 114597-114597
Closed Access
CircVPS8 promotes the malignant phenotype and inhibits ferroptosis of glioma stem cells by acting as a scaffold for MKRN1, SOX15 and HNF4A
Jinpeng Hu, Xinqiao Li, Kai Xu, et al.
Oncogene (2024) Vol. 43, Iss. 36, pp. 2679-2695
Closed Access | Times Cited: 2
Jinpeng Hu, Xinqiao Li, Kai Xu, et al.
Oncogene (2024) Vol. 43, Iss. 36, pp. 2679-2695
Closed Access | Times Cited: 2
Glioblastoma mesenchymal subtype enhances antioxidant defence to reduce susceptibility to ferroptosis
Simona D’Aprile, Simona Denaro, Alessandro Lavoro, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Simona D’Aprile, Simona Denaro, Alessandro Lavoro, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Novel approaches targeting ferroptosis in treatment of glioma
Jingxin Zhao, Feng-Ling Zang, Xiaoya Huo, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 6
Jingxin Zhao, Feng-Ling Zang, Xiaoya Huo, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 6
The research landscape of ferroptosis in neurodegenerative disease: a bibliometric analysis
Yun Liu, Dan Feng, Ling Shui, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 1
Yun Liu, Dan Feng, Ling Shui, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 1
Ferroptosis driven by nanoparticles for tackling glioblastoma
A Carlos, Maria Mendes, Maria Teresa Cruz, et al.
Cancer Letters (2024), pp. 217392-217392
Open Access | Times Cited: 1
A Carlos, Maria Mendes, Maria Teresa Cruz, et al.
Cancer Letters (2024), pp. 217392-217392
Open Access | Times Cited: 1
An atlas of causal and mechanistic drivers of interpatient heterogeneity in glioma
Serdar Turkarslan, Y.-Q. He, Parvinder Hothi, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Serdar Turkarslan, Y.-Q. He, Parvinder Hothi, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Procyanidin B1 Promotes PSMC3‐NRF2 Ubiquitination to Induce Ferroptosis in Glioblastoma
Wei Gao, Yuan Li, Xiang Lin, et al.
Phytotherapy Research (2024)
Open Access
Wei Gao, Yuan Li, Xiang Lin, et al.
Phytotherapy Research (2024)
Open Access
Lipidomics-driven drug discovery and delivery strategies in glioblastoma
Xiaohui Weng, Michael Gonzalez, Jeannes Angelia, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1871, Iss. 3, pp. 167637-167637
Open Access
Xiaohui Weng, Michael Gonzalez, Jeannes Angelia, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1871, Iss. 3, pp. 167637-167637
Open Access
Network-targeting combination therapy of leptomeningeal glioblastoma using multiple synthetic lethal strategies: a case report
Michael Castro, Bence Sipos, Saskia Biskup, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 1
Michael Castro, Bence Sipos, Saskia Biskup, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 1
Impact of Ferroptosis Inducers on Chronic Radiation-exposed Survivor Glioblastoma Cells
İlknur Sur‐Erdem
Anti-Cancer Agents in Medicinal Chemistry (2023) Vol. 23, Iss. 19, pp. 2154-2160
Closed Access
İlknur Sur‐Erdem
Anti-Cancer Agents in Medicinal Chemistry (2023) Vol. 23, Iss. 19, pp. 2154-2160
Closed Access